iCAD, Inc.
iCAD, Inc. (ICAD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ICAD · as of Jun 9, 2026
Key Statistics
Explore iCAD, Inc. Data
icad stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 80.0%
Competitors & Peers
icad competitorsICAD
ASXC
AUGX
CYT
FVE
GENEStock Performance
Full HistoryAbout iCAD, Inc.
iCAD, Inc. specializes in delivering advanced solutions for cancer management, encompassing sophisticated image analysis tools, streamlined workflow optimization, and targeted radiation therapy. While…
what is icad, inc. · icad stock overview · icad, inc. company profile · who is icad, inc. ceo · icad NASDAQ · icad, inc. headquarters · icad, inc. business segments
About Stock Overview & Key Data
iCAD, Inc. (ICAD) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Dec 13, 1984. As of the latest trading session, ICAD stock price is $3.87, with a market capitalization of $106.3M. The stock has returned +130.36% over the past 12 months and +94.47% year-to-date.
According to 10 Wall Street analysts, the consensus rating for iCAD, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, iCAD, Inc. reported revenue of $19.6M and net income of -$5.6M. For detailed data — including iCAD, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, iCAD, Inc. (ICAD) stock price is $3.87. The stock is traded on NASDAQ under the ticker symbol ICAD. The 52-week range is $1.19 – $4.01.